Zestra UK Announces Notice of Allowance for Zestra® Patent by European Patent Office Tuesday 24 April 2007 PDF Print Zestra UK Announces Notice of Allowance for Zestra® Patent by European Patent Office Leading Non-Prescription Intimacy Product Quickly Enhances Female Sexual Pleasure and is Hormone-free and Paraben-free London, UK – April 24, 2007 – Zestra Laboratories announced today that it has received a notice of allowance from the European Patent Office (EPO) accepting its patent application for Zestra® Feminine Arousal Oil (Compositions and Methods for enhancing female sexual response). In 2006, Zestra® became the leading dollar volume women's intimacy product in the United States and is now available in the UK. The EPO has stated that it intends to grant patent protection covering the proprietary formulation for Zestra®, including its manufacture. In 2004, the Company was awarded a United States patent (U.S. Patent 6,737,084) for Zestra® Feminine Arousal Oil (Compositions and Methods for enhancing female sexual response). Nick O’Hare, Director of Zestra UK, comments: "The notice of allowance from the EPO significantly expands the intellectual property protection of our breakthrough women’s intimacy product. It shows that Zestra is unique, unlike any other sexual enhancement product and that women can trust Zestra because it has been reliably tested and scientifically developed. Zestra® offers women the convenience of being topically-applied prior to a sexual encounter and quickly enhances the natural process of female sexual arousal and pleasure. Zestra® has been rapidly adopted as the reliable option for older women whose sexual response is not what it used to be , as well as by women who are seeking to enhance their lovemaking experience. “Zestra® helps a woman’s body to do what it did naturally when she was younger”, added O’Hare. “The growing worldwide use of Zestra® has shown that enhancing their sexual experience is something that women see as important to a satisfying and stable relationship” About Zestra® Feminine Arousal Oil (U.S. Patent 6,737,084) Zestra Laboratories, Inc., a speciality consumer health products company, is the developer and manufacturer of Zestra® Feminine Arousal Oil, a patented all-natural formulation of two botanical oils and two extracts. Zestra®, which is easy to use and when topically applied, helps enhance the natural process of arousal and sensation for most women within three to five minutes. The effects of each application last up to 45 minutes. It is the only consumer product clinically shown to quickly enhance female sexual sensation, arousal and sexual pleasure. This over the counter product is hormone-free and Paraben-free which is important for health conscious women. For more information, visit www.zestra.co.uk. -ends- Editor's Notes: Interviews with board members and company executives are available. Contacts: Zestra Press Office Image Box UK Ltd Millie Kitch or Michelle Boxall Tel: 020 8943 4685 Email: firstname.lastname@example.org This press release was distributed by ResponseSource Press Release Wire on behalf of Image Box in the following categories: Men's Interest, Health, Women's Interest & Beauty, Medical & Pharmaceutical, for more information visit http://pressreleasewire.responsesource.com/about.